Project Grant HT94252310244
Award Date
5/1/23
Completion Date
4/30/27
Dollars Obligated
$1.7M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
The Icahn School of Medicine at Mount Sinai will receive $1,678,688 under a four-year Project Grant from the Defense Health Agency's Military Medical Research and Development program to investigate the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. The research aims to transform military and public health through innovative medical solutions for the battlefield by supporting basic, applied, and advanced biomedical...
The Defense Health Agency awarded a $2,475,390.00 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from September 1, 2024 to August 31, 2028, will fund a multifaceted intervention titled "MULTIFACETED INTERVENTION TO RESTORE RESILIENCE AND OVERCOME RISK (MIRROR)." As a renowned academic medical center, ISMMS will leverage its expertise in areas such as...
The Defense Health Agency has awarded a $766,079 Project Grant to the Icahn School of Medicine at Mount Sinai to conduct research under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from September 1, 2023 to August 31, 2026, aims to "UNRAVEL THE EVOLUTION OF MELANOMA WITHIN THE HOST IMMUNE ECOSYSTEM." As a leading private medical research institution, the Icahn School of Medicine at Mount Sinai has a history of providing a wide range of...
The U.S. Department of Defense's Defense Health Agency awarded a $319,204 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) to conduct research on "Advanced Brain Age Modeling in Multiple Sclerosis: Toward a Prognostic Biomarker for Personalized Medicine." The award, which runs from August 15, 2024, to August 14, 2026, is part of the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research initiatives aimed at...
The Icahn School of Medicine at Mount Sinai will receive $1,521,002 under a three-year Project Grant award from the Defense Health Agency. The grant will support research from August 1, 2023 to July 31, 2026 under the Military Medical Research and Development program (CFDA 12.420). Specifically, the funding will enable research to determine the contribution of lineage intermediate tumor cells during progression to T-SCNC. This work aligns with the Military Medical Research and Development...
This federal Project Grant award, in the amount of $2,028,000.00, was issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The award, with a performance period from April 1, 2025 to March 31, 2028, will fund research at the Icahn School of Medicine at Mount Sinai (ISMMS) to identify epigenetically driven vulnerabilities in metastatic castration-resistant prostate cancer. ISMMS is a prominent academic medical center and research...
The Icahn School of Medicine at Mount Sinai will receive $760,500 from the Defense Health Agency under a three-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to functionally identify high-dimensional driver combinations in basal-like breast cancer. Through February 1, 2023 to January 31, 2026, this award will support the Icahn School of Medicine's efforts to transform health care for service members and the...
This Project Grant award, valued at $999,975.63, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on investigating the molecular mechanisms of APOE4 vulnerability to Alzheimer's disease and identifying novel therapeutic targets. The award was granted to the Icahn School of Medicine at Mount Sinai, a prominent academic medical center and research...
The Icahn School of Medicine at Mount Sinai was awarded a $505,270 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on September 30, 2025, will support research to investigate the impact of the reprogrammed PIK3R1-insulin-glucose metabolism pathway in lethal prostate cancer, with the goal of developing a new therapeutic strategy. This research project, which has a performance period...
The Defense Health Agency awarded a $749,991 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Icahn School of Medicine at Mount Sinai. The grant, titled "WNT-MODULATORY HYDROGEL PATCH FOR ROTATOR CUFF MUSCLE FATTY DEGENERATION", supports the development of an innovative hydrogel patch to address rotator cuff muscle fatty degeneration, a common condition affecting military personnel. The Icahn School of Medicine at Mount Sinai, a prominent...